-
IntroducedJun 04, 2025
-
Passed House
-
Passed Senate
-
Signed into Law
To amend title XI of the Social Security Act to establish a research and development-intensive small biotech manufacturer exception from the Medicare drug price negotiation program.
Last Action See all actions
House • Jun 04, 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Summary/Bill Text
Comments on HR 3731
Tweets
Whip Lists
Sponsors
Votes
Actions
- Jun 04, 2025 | House
- Introduced in House
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Bill Texts
Documents